ArticleMolecular and cellular biology1996

A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma.

P I Knaus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.